查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1869877

冠状动脉绕道手术手术市场规模、份额和趋势分析报告：按技术、手术方式、最终用途、地区和细分市场预测（2025-2033 年）

Coronary Artery Bypass Graft Market Size, Share & Trends Analysis Report By Method (On-pump, Off-pump), By Surgical Procedure (Single CABG Surgery, Double CABG Surgery), By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

冠状动脉绕道手术手术市场摘要

2024年全球冠状动脉绕道手术手术市场规模估计为192.4亿美元，预计2033年将达到276.6亿美元。

预计从2025年到2033年，该市场将以3.86%的复合年增长率成长。心血管疾病盛行率的上升是推动市场成长的主要因素之一。

根据牛津学术出版社2025年1月发表的报导，心血管疾病的全球负担依然沉重，年龄已调整的盛行率约为每10万人7179例。如此高的盛行率凸显了对有效治疗方法的日益增长的需求，特别是对冠状动脉疾病的治疗方法，冠状动脉疾病是心血管相关疾病和死亡的主要原因。

冠状动脉疾病 (CAD) 盛行率的不断上升正在推动市场成长。根据美国疾病管制与预防美国(CDC) 于 2024 年 10 月发布的报告，CAD 影响着美国约 5% 的成年人（20 岁及以上），即近 1/20 的人患有 CAD。如此高的盛行率凸显了 CAD 的持续挑战，CAD 仍然是心臟相关疾病和死亡的主要原因之一。对于许多患者而言，晚期 CAD 病例需要手术干预，因为微创治疗效果有限。因此，冠状动脉绕道手术手术 (CABG) 仍然是一种至关重要的治疗方法，这不仅巩固了其在整体心血管护理中的重要性，也凸显了其作为市场格局关键驱动因素的作用。

移植技术的进步正为冠状动脉绕道手术（CABG）带来更有效、更持久的解决方案。例如，2025年7月，创新植入开发商Xeltis推出了Xabg，一种人工合成冠状动脉绕道手术移植血管（CABG）。这种创新移植血管旨在促进血管内皮细胞自然形成，进而维持血管的通畅。欧盟临床试验的初步数据显示，Xabg在多支血管粥状硬化性冠状动脉疾病患者中具有良好的安全性和通畅率。 Xabg是移植技术的突破性进展，旨在透过促进内皮细胞生长并整合到患者自身血管系统中，克服传统移植血管的限制。

此外，机器人技术在冠状动脉绕道手术（CABG）的应用正在改变手术方式，提高手术精准度并降低创伤。根据OAE Publishing Inc.于2025年8月发表的报导，机器人辅助CABG正逐渐成为传统开胸手术的一种微创替代方案，可减少手术创伤并加速康復。具体技术包括机器人辅助微创直接冠状动脉绕道手术（RA-MIDCAB），该手术使用机器人采集内乳动脉，并透过小切口进行吻合。还有完全内视镜冠状动脉绕道手术（TECAB），该手术完全避免了开胸。这些进步正在重塑手术计划和实施，提高冠状动脉重组手术的精确度并降低创伤。

在美国，冠状动脉绕道手术（CABG）的报销格局正在迅速变化，反映出医疗产业向价值医疗模式的转变。引入综合支付模式以简化报销流程并提升医疗品质是一大趋势。根据美国心臟学会基金会（ACCF）2024年4月发布的公告，美国医疗保险和医疗补助服务中心（CMS）已提案一项强制性的医院按病程付费模式－「转型病程责任制模式」（TEAM），该模式将于2026年1月开始实施。此模式整合了冠状动脉绕道术（CABG）和其他高成本手术的支付，确保报销更加可预测，并鼓励医院优化诊疗路径，从而改善患者预后。

除了打包支付之外，医师收费标准（PFS）的更新也影响报销趋势。根据Atricure的报导，将于2025年1月1日生效的Medicare PFS将修订冠状动脉旁路移植术（CABG）的报销费率，使单支动脉移植CABG（CPT代码33533）的费用约为1789美元。这些调整将提高医院和外科医生进行复杂心血管手术的合理报酬，并确保支付与目前的临床实践和营运成本相符。

此外，微创冠状动脉绕道手术（CABG）医疗覆盖范围的扩大，反映了人们对先进外科手术方法的接受度不断提高。自2025年1月起，罗德岛蓝十字蓝盾保险公司更新了其医疗保险政策，将微创直接冠状动脉绕道手术（MIDCAB）纳入健保范围。该政策认可微创手术的许多好处，包括缩短恢復时间和改善患者预后。然而，其他微创手术方法，例如经皮冠状动脉绕道手术移植术（PACAB）和全内视镜冠状动脉绕道手术（TECAB），由于缺乏改善预后的证据，仍不在医保覆盖范围内。

目录

第一章调查方法和范围

第二章执行摘要

第三章冠状动脉绕道手术手术市场变数、趋势与范围

  • 市场体系展望
    • 补贴市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 冠状动脉绕道手术手术：市场分析工具
    • 产业分析—波特五力分析
    • PESTLE分析
  • 未来机会分析
    • 组织工程血管移植物（TEVG）
    • 高风险多支血管冠状动脉疾病（CAD）患者对冠状动脉绕道手术（CABG）的需求不断增加
    • 将人工智慧和影像技术整合到术前规划中
  • 技术格局
    • 技术和程序创新
    • 移植材料的进展
    • 3D列印在外科手术规划的应用
  • 冠状动脉绕道手术市场的临床和手术趋势
  • 案例研究
  • 冠状动脉绕道手术的替代方案

第四章冠状动脉绕道手术手术市场区隔分析（依技术划分，2021-2033年）

  • 定义和范围
  • 技术市场占有率分析，2024 年和 2033 年
  • 细分仪表板
  • 全球冠状动脉绕道手术手术市场（依技术划分），2021-2033年
  • 非泵送
  • 泵浦上
  • 微创直接冠状动脉绕道手术（MIDCAB）

第五章冠状动脉绕道手术手术市场区隔分析（依手术方式划分），2021年至2033年

  • 定义和范围
  • 外科手术市场占有率分析，2024 年和 2033 年
  • 细分仪表板
  • 全球冠状动脉绕道手术手术市场（依手术方式划分，2021-2033 年）
  • 单次冠状动脉绕道手术
  • 双侧冠状动脉绕道手术
  • 三重冠状动脉旁路移植术
  • 四重冠状动脉绕道手术

第六章冠状动脉绕道手术手术市场区隔分析（依最终用途划分），2021年至2033年

  • 定义和范围
  • 2024 年及 2033 年终端用户市占率分析
  • 细分仪表板
  • 全球冠状动脉绕道手术手术市场（依最终用途划分），2021-2033年
  • 医院
  • 心臟病中心
  • 其他的

第七章冠状动脉绕道手术手术市场細項分析，依地区、技术、手术方式、最终用途划分，2021-2033年

  • 2024 年及 2033 年区域市占率分析
  • 区域市场概览
  • 区域市场概况
  • 2024 年及 2033 年各地区冠状动脉绕道手术手术市占率：
  • 北美洲
    • 2021-2033年北美冠状动脉绕道手术手术市场
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2021-2033年欧洲冠状动脉绕道手术手术市场
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 公司简介
    • Medtronic
    • Terumo Corporation
    • Getinge AB
    • WL Gore &Associates, Inc.
    • B. Braun SE
    • Abbott.
    • LivaNova plc
    • Transonic
    • Edwards Lifesciences
    • Vascular Graft Solutions
Product Code: GVR-1-68038-426-0

Coronary Artery Bypass Graft Market Summary

The global coronary artery bypass graft market size was estimated at USD 19.24 billion in 2024 and is projected to reach USD 27.66 billion by 2033, growing at a CAGR of 3.86% from 2025 to 2033. Increasing the prevalence of cardiovascular disease is one of the key aspects driving market growth.

According to an Oxford Academic article published in January 2025, the global burden of cardiovascular disease remains substantial, with an age-standardized prevalence of approximately 7,179 cases per 100,000 individuals. This high prevalence underlines the growing need for effective treatment options, particularly for coronary artery disease, which is a leading contributor to cardiovascular-related morbidity and mortality.

The increasing incidence of CAD drives market growth. According to the CDC article published in October 2024, in the U.S., coronary artery disease (CAD) affects a significant portion of the population, with nearly 1 in 20 adults aged 20 years and older, approximately 5% living with the condition. This sizable patient pool highlights the ongoing clinical challenge posed by CAD, which remains a leading cause of heart-related morbidity and mortality. For many individuals, advanced cases of CAD require surgical intervention when less invasive treatments prove insufficient. As a result, coronary artery bypass grafting (CABG) continues to serve as a vital therapeutic approach, reinforcing its importance within the broader cardiovascular treatment landscape and underscoring its role as a key driver of market demand.

Advancements in graft technology are paving the way for more effective and durable solutions in CABG procedures. For instance, in July 2025, Xeltis, a transformative implant developer, introduced Xabg, a synthetic coronary artery bypass conduit (CABG). This innovative graft is designed to enable the natural creation of living and long-lasting vessels. Preliminary clinical data from an EU clinical trial have demonstrated positive safety and patency outcomes among patients with multi-vessel atherosclerotic coronary artery disease. Xabg represents a significant advancement in graft technology, aiming to address the limitations of traditional grafts by promoting endothelial cell growth and integration with the patient's vascular system.

Moreover, integrating robotics into CABG procedures transforms surgical approaches, offering enhanced precision and reduced invasiveness. According to OAE Publishing Inc., an article published in August 2025, Robotic-assisted CABG has emerged as a minimally invasive alternative to traditional open-heart surgery, offering reduced surgical trauma and faster recovery. Techniques include robotic-assisted minimally invasive direct coronary artery bypass (RA-MIDCAB), where the internal thoracic artery is harvested robotically and anastomosed via mini-thoracotomy, and totally endoscopic CABG (TECAB), which avoids thoracotomy altogether. These advancements reshape operative planning and execution, enhancing precision and reducing invasiveness in coronary revascularization procedures.

The landscape of CABG reimbursement in the U.S. is evolving rapidly, reflecting the healthcare industry's push toward value-based care. A significant trend is the introduction of bundled payment models that streamline reimbursement and incentivize quality. According to the American College of Cardiology Foundation in April 2024, the Centers for Medicare & Medicaid Services (CMS) proposed the Transforming Episode Accountability Model (TEAM), a mandatory hospital episode-based payment model set to start in January 2026. This model bundles payments for CABG surgeries and other high-cost procedures, ensuring more predictable reimbursement and encouraging hospitals to optimize care pathways for improved patient outcomes.

Parallel to bundled payments, physician fee schedule updates have shaped reimbursement trends. According to an Atricure article, effective January 1, 2025, the Medicare Physician Fee Schedule (PFS) revised reimbursement rates for CABG procedures, including the single arterial graft CABG (CPT code 33533) at approximately USD 1,789. These adjustments ensure payments align with current clinical practice and operational costs, reinforcing fair compensation for hospitals and surgeons performing complex cardiac procedures.

Moreover, expanding coverage for minimally invasive CABG techniques reflects increasing acceptance of advanced surgical approaches. As of January 2025, Blue Cross Blue Shield of Rhode Island updated its medical policy to cover Minimally Invasive Direct Coronary Artery Bypass (MIDCAB) surgery. The policy recognizes the benefits of less invasive procedures, such as reduced recovery times and enhanced patient outcomes. However, other minimally invasive approaches, such as Port Access CABG (PACAB) and Total Endoscopic CABG (TECAB), remain excluded due to limited evidence of improved outcomes.

Global Coronary Artery Bypass Graft Market Report Segmentation

This report forecasts revenue and volume growth at global, regional, and country levels and analyzes industry trends in each sub-segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the global coronary artery bypass graft market report based on method, surgical procedure, end-use, and region:

  • Method Outlook (Revenue USD Million, 2021 - 2033)
  • Off-pump
  • On-pump
  • Minimally Invasive Direct CABG (MIDCAB)
  • Surgical Procedure Outlook (Revenue USD Million, 2021 - 2033) (Procedure Volume, In Thousand, 2021 - 2033)
  • Single CABG Surgery
  • Double CABG Surgery
  • Triple CABG Surgery
  • Quadruple CABG Surgery
  • End-use Outlook (Revenue USD Million, 2021 - 2033)
  • Hospitals
  • Cardiology Centers
  • Others
  • Regional Outlook (Revenue USD Million, 2021 - 2033) (Procedure Volume, In Thousand, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Spain
    • Italy
    • France
    • Denmark
    • Norway
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Method outlook
    • 2.2.2. Surgical Procedure outlook
    • 2.2.3. End Use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Coronary Artery Bypass Graft Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising cardiovascular (CVD) and coronary artery disease (CAD) prevalence
      • 3.2.1.2. Technological advances in grafts & robotics
      • 3.2.1.3. Increasing favorable reimbursement policies for CABG
      • 3.2.1.4. Increasing favorable reimbursement policies for CABG
      • 3.2.1.5. AI-Guided Intra-Operative Imaging Adoption
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Operational and procedural hurdles restrict advanced CABG techniques
      • 3.2.2.2. Surgical complexity and associated risks in CABG
  • 3.3. Coronary Artery Bypass Graft: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis
  • 3.4. Future Opportunity Analysis
    • 3.4.1. Tissue-Engineered Vascular Grafts (TEVGs)
    • 3.4.2. Growing CABG Demand In High-Risk, Multi-Vessel CAD Patients
    • 3.4.3. AI and Imaging Integration In Pre-Surgical Planning
  • 3.5. Technology Landscape
    • 3.5.1. Technological And Procedural Innovations
    • 3.5.2. Advancements In Graft Materials
    • 3.5.3. 3D Printing In Surgical Planning
  • 3.6. Clinical & Procedural Trends in the CABG Market
  • 3.7. Case Studies
  • 3.8. Alternative Methods to CABG

Chapter 4. Coronary Artery Bypass Graft Market Segment Analysis, By Method, 2021 - 2033 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Method Market Share Analysis, 2024 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global Coronary Artery Bypass Graft Market, by Method, 2021 - 2033
  • 4.5. Off-pump
    • 4.5.1. Off-pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. On-pump
    • 4.6.1. On-pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Minimally Invasive Direct CABG (MIDCAB)
    • 4.7.1. Minimally Invasive Direct CABG (MIDCAB) market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Coronary Artery Bypass Graft Market Segment Analysis, By Surgical Procedure, 2021 - 2033 (USD Million) (Thousands)

  • 5.1. Definition and Scope
  • 5.2. Surgical Procedure Market Share Analysis, 2024 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Global Coronary Artery Bypass Graft Market, by Surgical Procedure, 2021 - 2033
  • 5.5. Single CABG Surgery
    • 5.5.1. Single CABG surgery market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.5.2. Single CABG surgery market estimates and forecasts, 2021 - 2033 (In Thousand)
  • 5.6. Double CABG Surgery
    • 5.6.1. Double CABG surgery market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.6.2. Double CABG surgery market estimates and forecasts, 2021 - 2033 (In Thousand)
  • 5.7. Triple CABG Surgery
    • 5.7.1. Triple CABG surgery market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.7.2. Triple CABG surgery market estimates and forecasts, 2021 - 2033 (In Thousand)
  • 5.8. Quadruple CABG Surgery
    • 5.8.1. Quadruple CABG surgery market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.8.2. Quadruple CABG surgery market estimates and forecasts, 2021 - 2033 (In Thousand)

Chapter 6. Coronary Artery Bypass Graft Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. End Use Market Share Analysis, 2024 & 2033
  • 6.3. Segment Dashboard
  • 6.4. Global Coronary Artery Bypass Graft Market, by end use, 2021 - 2033
  • 6.5. Hospitals
    • 6.5.1. Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Cardiology Centers
    • 6.6.1. Cardiology Centers market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Coronary Artery Bypass Graft Market Segment Analysis, By Region, By Method, By Surgical Procedure, By End Use, 2021 - 2033 (USD Million)

  • 7.1. Regional Market Share Analysis, 2024 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Regional Market Snapshot
  • 7.4. Coronary Artery Bypass Graft Market Share by Region, 2024 & 2033:
  • 7.5. North America
    • 7.5.1. North America Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory Framework & Reimbursement Scenario
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. U.S. Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.5.2.5. U.S. Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.5.3. Canada
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory Framework & Reimbursement Scenario
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Canada Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.5.3.5. Canada Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.5.4. Mexico
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory Framework & Reimbursement Scenario
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Mexico Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.5.4.5. Mexico Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
  • 7.6. Europe
    • 7.6.1. Europe Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
    • 7.6.2. UK
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory Framework & Reimbursement Scenario
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. UK Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.6.2.5. UK Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.6.3. Germany
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory Framework & Reimbursement Scenario
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Germany Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.6.3.5. Germany Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.6.4. France
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory Framework & Reimbursement Scenario
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. France Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.6.4.5. France Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.6.5. Italy
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory Framework & Reimbursement Scenario
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Italy Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.6.5.5. Italy Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.6.6. Spain
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory Framework & Reimbursement Scenario
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Spain Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.6.6.5. Spain Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.6.7. Norway
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory Framework & Reimbursement Scenario
      • 7.6.7.3. Competitive Scenario
      • 7.6.7.4. Norway Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.6.7.5. Norway Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.6.8. Sweden
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory Framework & Reimbursement Scenario
      • 7.6.8.3. Competitive Scenario
      • 7.6.8.4. Sweden Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.6.8.5. Sweden Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.6.9. Denmark
      • 7.6.9.1. Key country dynamics
      • 7.6.9.2. Regulatory Framework & Reimbursement Scenario
      • 7.6.9.3. Competitive Scenario
      • 7.6.9.4. Denmark Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.6.9.5. Denmark Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory Framework & Reimbursement Scenario
      • 7.7.1.3. Competitive Scenario
      • 7.7.1.4. Japan Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.7.1.5. Japan Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory Framework & Reimbursement Scenario
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. China Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.7.2.5. China Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory Framework & Reimbursement Scenario
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. India Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.7.3.5. India Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory Framework & Reimbursement Scenario
      • 7.7.4.3. Competitive Scenario
      • 7.7.4.4. Australia Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.7.4.5. Australia Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory Framework & Reimbursement Scenario
      • 7.7.5.3. Competitive Scenario
      • 7.7.5.4. South Korea Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.7.5.5. South Korea Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory Framework & Reimbursement Scenario
      • 7.7.6.3. Competitive Scenario
      • 7.7.6.4. Thailand Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.7.6.5. Thailand Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory Framework & Reimbursement Scenario
      • 7.8.1.3. Competitive Scenario
      • 7.8.1.4. Brazil Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.8.1.5. Brazil Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory Framework & Reimbursement Scenario
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. Argentina Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.8.2.5. Argentina Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory Framework & Reimbursement Scenario
      • 7.9.1.3. Competitive Scenario
      • 7.9.1.4. South Africa Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.9.1.5. South Africa Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory Framework & Reimbursement Scenario
      • 7.9.2.3. Competitive Scenario
      • 7.9.2.4. Saudi Arabia Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.9.2.5. Saudi Arabia Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory Framework & Reimbursement Scenario
      • 7.9.3.3. Competitive Scenario
      • 7.9.3.4. UAE Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.9.3.5. UAE Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory Framework & Reimbursement Scenario
      • 7.9.4.3. Competitive Scenario
      • 7.9.4.4. Kuwait Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.9.4.5. Kuwait Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Profiles
    • 8.3.1. Medtronic
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Terumo Corporation
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Getinge AB
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. W. L. Gore & Associates, Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. B. Braun SE
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Abbott.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. LivaNova plc
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Transonic
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Edwards Lifesciences
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Vascular Graft Solutions
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 4. Global Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 5. Global Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (In Thousand)
  • Table 6. Global Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 7. Global Coronary Artery Bypass Graft Market, By Region, 2021 - 2033 (USD Million)
  • Table 8. North America Coronary Artery Bypass Graft Market, By Country, 2021 - 2033 (USD Million)
  • Table 9. North America Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 10. North America Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 11. North America Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 12. North America Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13. U.S. Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 14. U.S. Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 15. U.S. Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 16. U.S. Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17. Canada Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 18. Canada Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 19. Canada Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 20. Canada Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 21. Mexico Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 22. Mexico Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 23. Mexico Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 24. Mexico Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 25. Europe Coronary Artery Bypass Graft Market, By Country, 2021 - 2033 (USD Million)
  • Table 26. Europe Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 27. Europe Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 28. Europe Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 29. Europe Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30. UK Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 31. UK Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 32. UK Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 33. UK Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 34. Germany Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 35. Germany Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 36. Germany Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 37. Germany Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38. France Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 39. France Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 40. France Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 41. France Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42. Italy Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 43. Italy Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 44. Italy Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 45. Italy Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 46. Spain Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 47. Spain Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 48. Spain Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 49. Spain Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 50. Denmark Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 51. Denmark Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 52. Denmark Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 53. Denmark Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54. Sweden Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 55. Sweden Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 56. Sweden Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 57. Sweden Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58. Norway Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 59. Norway Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 60. Norway Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 61. Norway Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 62. Asia Pacific Coronary Artery Bypass Graft Market, By Country, 2021 - 2033 (USD Million)
  • Table 63. Asia Pacific Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 64. Asia Pacific Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 65. Asia Pacific Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 66. Asia Pacific Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67. Japan Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 68. Japan Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 69. Japan Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 70. Japan Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 71. China Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 72. China Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 73. China Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 74. China Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 75. India Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 76. India Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 77. India Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 78. India Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79. Australia Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 80. Australia Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 81. Australia Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 82. Australia Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 83. Thailand Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 84. Thailand Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 85. Thailand Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 86. Thailand Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 87. South Korea Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 88. South Korea Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 89. South Korea Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 90. South Korea Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 91. Latin America Coronary Artery Bypass Graft Market, By Country, 2021 - 2033 (USD Million)
  • Table 92. Latin America Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 93. Latin America Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 94. Latin America Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 95. Latin America Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 96. Brazil Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 97. Brazil Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 98. Brazil Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 99. Brazil Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 100. Argentina Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 101. Argentina Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 102. Argentina Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 103. Argentina Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 104. Middle East & Africa Coronary Artery Bypass Graft Market, By Country, 2021 - 2033 (USD Million)
  • Table 105. Middle East & Africa Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 106. Middle East & Africa Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 107. Middle East and Africa Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 108. Middle East & Africa Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 109. South Africa Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 110. South Africa Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 111. South Africa Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 112. South Africa Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 113. Saudi Arabia Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 114. Saudi Arabia Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 115. Saudi Arabia Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 116. Saudi Arabia Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 117. UAE Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 118. UAE Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 119. UAE Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 120. UAE Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 121. Kuwait Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 122. Kuwait Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 123. Kuwait Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 124. Kuwait Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Coronary artery bypass graft market: outlook
  • Fig. 8 Coronary artery bypass graft competitive insights
  • Fig. 9 Ancillary market outlook
  • Fig. 10 Coronary artery bypass graft market driver impact
  • Fig. 11 Coronary artery bypass graft market restraint impact
  • Fig. 12 Porter's Analysis
  • Fig. 13 PESTLE Analysis
  • Fig. 14 Coronary artery bypass graft market: Method movement analysis
  • Fig. 15 Coronary artery bypass graft market: Method outlook and key takeaways
  • Fig. 16 Off-pump market estimates and forecast, 2021 - 2033
  • Fig. 17 On-pump market estimates and forecast, 2021 - 2033
  • Fig. 18 Minimally Invasive Direct CABG (MIDCAB) market estimates and forecast, 2021 - 2033
  • Fig. 19 Coronary artery bypass graft market: Surgical procedure movement analysis
  • Fig. 20 Coronary artery bypass graft market: Surgical procedure outlook and key takeaways
  • Fig. 21 Single CABG surgery market estimates and forecasts, 2021 - 2033
  • Fig. 22 Double CABG surgery market estimates and forecasts, 2021 - 2033
  • Fig. 23 Triple CABG surgery market estimates and forecasts, 2021 - 2033
  • Fig. 24 Quadruple CABG surgery market estimates and forecasts, 2021 - 2033
  • Fig. 25 Coronary artery bypass graft market: End Use movement analysis
  • Fig. 26 Coronary artery bypass graft market: End Use outlook and key takeaways
  • Fig. 27 Hospitals market estimates and forecasts, 2021 - 2033
  • Fig. 28 Cardiology centers market estimates and forecasts,2021 - 2033
  • Fig. 29 Others centers market estimates and forecasts, 2021 - 2033
  • Fig. 30 Global coronary artery bypass graft market: Regional movement analysis
  • Fig. 31 Global coronary artery bypass graft market: Regional outlook and key takeaways
  • Fig. 32 North America coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 33 Key country dynamics
  • Fig. 34 US coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 35 Key country dynamics
  • Fig. 36 Canada coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 37 Key country dynamics
  • Fig. 38 Mexico coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 39 Europe coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 40 Key country dynamics
  • Fig. 41 UK coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 42 Key country dynamics
  • Fig. 43 Germany coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 44 Key country dynamics
  • Fig. 45 Spain coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 46 Key country dynamics
  • Fig. 47 France coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 48 Key country dynamics
  • Fig. 49 Italy coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 50 Key country dynamics
  • Fig. 51 Norway coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 52 Key country dynamics
  • Fig. 53 Denmark coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 54 Key country dynamics
  • Fig. 55 Sweden coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 56 Asia Pacific coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 57 Key country dynamics
  • Fig. 58 Japan coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 59 Key country dynamics
  • Fig. 60 China coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 61 Key country dynamics
  • Fig. 62 India coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 63 Key country dynamics
  • Fig. 64 Australia coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 65 Key country dynamics
  • Fig. 66 South Korea coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 67 Key country dynamics
  • Fig. 68 Thailand coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 69 Latin America coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 70 Key country dynamics
  • Fig. 71 Brazil coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 72 Key country dynamics
  • Fig. 73 Argentina coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 74 MEA coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 75 Key country dynamics
  • Fig. 76 South Africa coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 77 Key country dynamics
  • Fig. 78 Saudi Arabia coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 79 Key country dynamics
  • Fig. 80 UAE coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 81 Key country dynamics
  • Fig. 82 Kuwait coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 83 Key company categorization
  • Fig. 84 Heat map analysis, 2024